在前性,单中心,安慰剂控制,双盲研究中对Maskne进行评估
Alena Roessle1, Stefanie Gluecklich1, Martina Kerscher1
1Cosmetic Science, Institute of Biochemistry and Molecular Biology, University of Hamburg, Germany.
Journal of cosmetic dermatology
|August 23, 2025
概括
皮肤内注射的毒素A (INCO) 显著改善了女性的皮肤质量. 这种治疗减少了皮肤粗,皮脂,毛孔大小和红斑,为口罩相关的皮肤问题提供了有希望的解决方案.
科学领域:
- 皮肤病学
- 审美医学
- 美容科学
背景情况:
- 在COVID-19大流行期间出现了Maskne或口罩诱导的疹,对皮肤质量和健康产生了负面影响.
- 由于长时间使用口罩,医疗保健专业人员尤其受到maskne的影响.
- 关于皮肤内注射的毒素A (INCO) 对肌肉的疗效的数据有限.
研究的目的:
- 评估肌内INCO在改善肌肤质量的有效性.
- 评估INCO对特定皮肤参数的影响,如皮肤粗,皮脂,毛孔大小和红斑.
主要方法:
- 进行了一项前性,随机,双盲,安慰剂对照试验,涉及36名maskne妇女.
- 参与者在中部和下部接受皮内INCO (20U) 或安慰剂.
- 在112天内使用生物物理工具测量皮肤粗度 (SEr),皮脂水平,毛孔大小和红斑指数,并对患者和专家进行评估.
主要成果:
- 在整个112天的研究期间,INCO组与安慰剂相比,皮肤粗度 (SEr) 显著改善.
- 在INCO组28日观察到皮脂水平显著下降 (-19.27μg/ cm2).
- 在28日和56日观察到毛孔大小的显著差异,红的减少在INCO组中更大 (p=0. 041).
结论:
- 皮肤内注射的INCO可以作为一种有效的治疗方法,
- 这项研究提供了令人鼓舞的证据,证明INCO在改善面具使用影响皮肤质量的多个参数方面具有有效性.
- 需要进一步的研究,以充分确定INCO的长期益处和最佳使用.
相关概念视频
02:07Blind Procedures
13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
339
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
339
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
213
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
213